Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial

MHA Muskiet; L Tonneijck; MM Smits; MHH Kramer; DM Ouwens; B Hartmann; JJ Holst; DJW Touw; AHJ Danser; JA Joles; DH van Raalte

doi:10.2337/dc20-0902

Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial

MHA Muskiet, L Tonneijck, MM Smits, MHH Kramer, DM Ouwens, B Hartmann, JJ Holst, DJW Touw, AHJ Danser, JA Joles, DH van Raalte

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	2889-2893
Number of pages	5
Journal	Diabetes Care
Volume	43
Issue number	11
DOIs	https://doi.org/10.2337/dc20-0902
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc20-0902

Cite this

Muskiet, MHA., Tonneijck, L., Smits, MM., Kramer, MHH., Ouwens, DM., Hartmann, B., Holst, JJ., Touw, DJW., Danser, AHJ., Joles, JA., & van Raalte, DH. (2020). Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial. Diabetes Care, 43(11), 2889-2893. https://doi.org/10.2337/dc20-0902

@article{bf10d271729047fe8098760e1d5dac6c,

title = "Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial",

author = "MHA Muskiet and L Tonneijck and MM Smits and MHH Kramer and DM Ouwens and B Hartmann and JJ Holst and DJW Touw and AHJ Danser and JA Joles and {van Raalte}, DH",

year = "2020",

doi = "10.2337/dc20-0902",

language = "English",

volume = "43",

pages = "2889--2893",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association Inc.",

number = "11",

}

Muskiet, MHA, Tonneijck, L, Smits, MM, Kramer, MHH, Ouwens, DM, Hartmann, B, Holst, JJ, Touw, DJW, Danser, AHJ, Joles, JA & van Raalte, DH 2020, 'Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial', Diabetes Care, vol. 43, no. 11, pp. 2889-2893. https://doi.org/10.2337/dc20-0902

Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial. / Muskiet, MHA; Tonneijck, L; Smits, MM et al.

In: Diabetes Care, Vol. 43, No. 11, 2020, p. 2889-2893.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial

AU - Muskiet, MHA

AU - Tonneijck, L

AU - Smits, MM

AU - Kramer, MHH

AU - Ouwens, DM

AU - Hartmann, B

AU - Holst, JJ

AU - Touw, DJW

AU - Danser, AHJ

AU - Joles, JA

AU - van Raalte, DH

PY - 2020

Y1 - 2020

U2 - 10.2337/dc20-0902

DO - 10.2337/dc20-0902

M3 - Article

SN - 1935-5548

VL - 43

SP - 2889

EP - 2893

JO - Diabetes Care

JF - Diabetes Care

IS - 11

ER -